Join to View Full Profile
5323 Harry Hines BlvdDallas, TX 75390
Phone+1 214-645-0624
Fax+1 214-645-0078
Dr. Stuve is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of WashingtonResidency, Neurology, 1997 - 2000- University of WashingtonInternship, Internal Medicine, 1996 - 1997
Freie University Berlin Faculty of MedicineClass of 1993
Certifications & Licensure
TX State Medical License 2005 - 2026
CA State Medical License 2001 - 2023
WA State Medical License 2000 - 2023
American Board of Psychiatry and Neurology Neurology
Clinical Trials
- Alternative Treatment Paradigm for Natalizumab Trial Start of enrollment: 2013 Jul 01
- Sequential Natalizumab - Alemtuzumab Therapy in Patients With Relapsing Forms of Multiple Sclerosis Start of enrollment: 2018 May 01
Publications & Presentations
PubMed
- Multiple sclerosis treatments a review of current biomedical engineering approaches.Sayyed Ourmazd Mohseni, Kin Man Au, Wadih Issa, Lifu Ruan, Olaf Stuve
Biomaterials. 2025-02-01 - 6 citationsSafety and efficacy of evobrutinib in relapsing multiple sclerosis (evolutionRMS1 and evolutionRMS2): two multicentre, randomised, double-blind, active-controlled, pha...Xavier Montalban, Patrick Vermersch, Douglas L Arnold, Amit Bar-Or, Bruce A C Cree
The Lancet. Neurology. 2024-11-01 - 3 citationsRole of B Cells in Relapsing-Remitting and Progressive Multiple Sclerosis and Long-Term Effects of B Cell Depletion.Afsaneh Shirani, Olaf Stuve, Anne H Cross
Neurologic Clinics. 2024-02-01
Press Mentions
Immunoablation Followed by Stem Cell Reconstitution Halts Aggressive MS for Five-plus Years, but Adverse Events Remain a ConcernJuly 7th, 2016
Multiple Sclerosis: Smoking After Diagnosis Linked to Disease ProgressionSeptember 9th, 2015
Quitting Smoking After MS Diagnosis May Delay Disease ProgressionSeptember 8th, 2015- Join now to see all
Grant Support
- Defining the role of CD11c+CD88+CD317+ myeloid cells as mediators of CNS autoimmunityVA NORTH TEXAS HEALTH CARE SYSTEM2021–2026
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
